Top Suppliers:I want be here

146724-86-9

146724-86-9 structure
146724-86-9 structure

Name mahma nonoate
Synonyms MFCD01310509
METHYLAMINE HEXAMETHYLENE METHYLAMINE NONOATE
noc-9crystalline
2-Hydroxy-1-methyl-1-[6-(methylamino)hexyl]-3-oxotriazane
6-(2-Hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-hexanamine NOC-9
1-Hexanamine, 6-(2-hydroxy-1-methyl-3-oxotriazanyl)-N-methyl-
NOC-9
MAHMA/NO
Description MAHMA NONOate is a NO donor. MAHMA NONOate effectively inhibits platelet aggregation induced by either collagen or ADP[1].
Related Catalog
In Vitro MAHMA NONOate (0.1 nM-100 μM) dose-dependently inhibits platelet aggregation induced by either collagen or ADP[1]. MAHMA NONOate shows inhibitory effects to pulmonary artery and platelet aggregation with log IC50 values of 7.18 and 6.16, respectively[1].
In Vivo MAHMA NONOate (0.3-10 nmol/kg/min; i.v. once) shows both platelet inhibitory and vasodepressor effects in vivo[2]. Animal Model: Male Wistar rats anaesthetised with pentobarbitone[2] Dosage: 0.3-10 nmol/kg/min Administration: Intravenous injection; 0.3-10 nmol/kg/min once Result: Dose-dependently decreased in mean systemic artery pressure and showd a more potent effect than GSNO. Caused dose-dependent inhibition of the response to 0.3 μM/kg ADP.
Density 1.1±0.1 g/cm3
Boiling Point 301.7±44.0 °C at 760 mmHg
Melting Point 102-108ºC
Molecular Formula C8H20N4O2
Molecular Weight 204.270
Flash Point 136.3±28.4 °C
Exact Mass 204.158630
PSA 68.17000
LogP 0.44
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.503
Storage condition 20°C
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Safety Phrases S24/25
RIDADR NONH for all modes of transport